17-361
Showing 1 - 25 of 4,488
Covid19 Trial in Sulaymaniyah (Xagrotin)
Completed
- Covid19
- Xagrotin
-
Sulaymaniyah, IraqDirectorate of health of Sulaimani, Iraq -KRG
Nov 30, 2021
Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Urothelial Carcinoma Associated 1 RNA, Human
- Pembrolizumab
- +3 more
- (no location specified)
Aug 18, 2022
Mesothelioma Trial in United States (pevonedistat, Pemetrexed and cisplatin)
Active, not recruiting
- Mesothelioma
- pevonedistat
- Pemetrexed and cisplatin
-
Basking Ridge, New Jersey
- +7 more
Sep 12, 2022
CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic
Recruiting
- CIN3
- +3 more
- Vvax001 therapeutic cancer vaccine
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Cannabis Trial (Cannabis, )
Not yet recruiting
- Cannabis
- Cannabis, placebo
- (no location specified)
Nov 10, 2022
Diabetes Trial in Chongqing (personalized lifestyle intervention by AI)
Not yet recruiting
- Diabetes
- personalized lifestyle intervention by AI
-
Chongqing, Chongqing, ChinaJinbo Hu
Nov 1, 2023
Head Neck Cancer Trial in United States (drug, radiation, procedure)
Tinnitus Trial in Hangzhou (Acupuncture)
Not yet recruiting
- Tinnitus
- Acupuncture
-
Hangzhou, Zhejiang, Chinathe Third Affiliated Hospital of Zhejiang Chinese Medical Univer
Apr 23, 2023
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Recruiting
- Gastro-intestinal Stromal Tumor
- Vena puncture for blood collection
- Tumor biopsy
-
Amsterdam, Netherlands
- +4 more
May 17, 2022
Heart Failure, Iron-deficiency Trial in Phoenix (IV Iron Infusion Group)
Enrolling by invitation
- Heart Failure
- Iron-deficiency
- IV Iron Infusion Group
-
Phoenix, ArizonaBanner - University Medical Center, Phoenix campus
Apr 14, 2023
SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)
Recruiting
- SARS-CoV-2
- +2 more
- mRNA-1010
- +4 more
-
DeLand, Florida
- +29 more
Jan 23, 2023
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)
Recruiting
- Neuroblastoma
- 131I-MIBG
- +4 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
A Cohort Study of Patients With Intracranial Hemorrhage
Recruiting
- Intracerebral Hemorrhage
- Routine clinical treatment
-
Beijing, Beijing, ChinaXuan Wu Hospital,Capital Medical University
Feb 27, 2023
Childhood Outcomes of Preterm Brain Abnormalities
Recruiting
- Premature Birth
- +3 more
- MRI
- Neurodevelopmental/Neuropsychological Assessment
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Jun 13, 2022
COPD Trial in Rahim yar khan (Anterior Chest Compression technique, Abdominal Thrust Technique)
Not yet recruiting
- COPD
- Anterior Chest Compression technique
- Abdominal Thrust Technique
-
Rahim yar khan, Punjab, PakistanSheikh Zayed Hospital, Rahim Yar Khan.
Jul 7, 2023
Augmented Reality Usage in Gynecological Laparoscopy on Patients
Active, not recruiting
- Myoma;Uterus
- Adenomyoma of Uterus
- Gynecological laparoscopic surgery without augmented reality
- Gynecological laparoscopic surgery with augmented reality
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2023
Host Microbiota and Il-17 in Favoring Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jan 26, 2023
Iron-deficiency Trial in Cape Town (FeFum fortified maize test meal, FeSO4 fortified LNS, FeSO4 supplement)
Completed
- Iron-deficiency
- FeFum fortified maize test meal
- +3 more
-
Cape Town, South AfricaFamiliy Clinical Research Unit (FAMCRU)
Sep 10, 2021
Psoriasis Vulgaris, UVB Phototherapy Burn Trial in Qina (Serum Interleukin 17 levels, NB-UVB)
Completed
- Psoriasis Vulgaris
- UVB Phototherapy Burn
- Serum Interleukin 17 levels
- NB-UVB
-
Qinā, Qena, EgyptSouth Valley University
Dec 9, 2022